KAI SCHIEMANN,DOMINIQUE SWINNEN,GUENTER HOELZEMANN,CARL DEUTSCH,DANIEL KUHN,ANSGAR WEGNER,HORACIO COMAS
申请号:
IL23446614
公开号:
IL234466A
申请日:
2014.09.04
申请国别(地区):
IL
年份:
2016
代理人:
摘要:
Compounds of the formula I in which R1, R2 and R4 have the meanings indicated in Claim 1, are inhibitors of GCN2, and can be employed, inter alia, for the treatment of cancer.